Apyx Medical
APYX
43 hedge funds and large institutions have $21.6M invested in Apyx Medical in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 5 closing their positions.
19,000% more call options, than puts
Call options by funds: $382K | Put options by funds: $2K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.52% less ownership
Funds ownership: 42.31% → 41.79% (-0.52%)
4% less funds holding
Funds holding: 45 → 43 (-2)
14% less capital invested
Capital invested by funds: $25.2M → $21.6M (-$3.53M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
56% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$216K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$122K |
| 3 |
SBCM
Silverberg Bernstein Capital Management
Armonk,
New York
|
+$104K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$80.6K |
| 5 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
+$54.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCA
Greenwood Capital Associates
Greenwood,
South Carolina
|
-$287K |
| 2 |
RA
Royce & Associates
New York
|
-$124K |
| 3 |
HWM
HB Wealth Management
Atlanta,
Georgia
|
-$79K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$72.7K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$63.1K |
APYX Hedge Fund Activity: Q1 2025 in Review
43 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2025, worth a combined $21.6M — down 14% from $25.2M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of APYX and 3 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 8 added.
The largest buyer was Archon Capital Management, adding an estimated $216K. The largest seller was Greenwood Capital Associates, cutting an estimated $287K.
- 43 institutional investors held Apyx Medical (APYX) as of Q1 2025, down from 45 in Q4 2024.
- Funds reported $21.6M of Apyx Medical stock for Q1 2025, down 14% quarter-over-quarter.
- 3 funds opened new Apyx Medical positions in Q1 2025 and 5 closed out, a net change of -2 holders.
- The largest Apyx Medical buyer in Q1 2025 was Archon Capital Management, an estimated $216K added.
- The largest Apyx Medical seller in Q1 2025 was Greenwood Capital Associates, an estimated $287K sold.
Based on aggregated 13F filings for Q1 2025.